Pfizer on Tuesday said results of Phase 2 clinical trials of its experimental Lyme disease vaccine delivered “positive” results, including among pediatric trial participants.
Alejandro Mayorkas told Congress that the Department of Homeland Security will maintain the security of the Southern Border on the same day that Border Patrol announced the apprehension of hundreds of migrants seeking to illegally enter the country.
Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a move toward potentially allowing shots for millions of youths by summer.
The Supreme Court will soon decide an abortion case in which Mississippi has asked the Justices to overturn Roe v. Wade. The oral argument suggested that five Justices lean toward doing so, but a ferocious lobbying campaign is trying to change their minds.
"Antibodies produced by vaccinated and boosted people may not stop omicron SARS-CoV-2 strain from entering cells as well as it stops original virus," say Johns Hopkins researchers.
The U.S. Food and Drug Administration (FDA) on Monday approved the use of the antiviral therapy, remdesivir, to treat COVID-19 in infants four weeks and older.
Ever since China launched its Belt and Road Initiative (BRI), some Western analysts have portrayed it as a geopolitical offensive designed to increase China’s influence in, and ultimately control of, Eurasia.
